| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827919 | European Urology Focus | 2017 | 4 Pages |
Abstract
In this study we analyzed the impact of surgery in patients with prostate cancer and bone metastases. Using prospective data, we could not show a significant benefit of surgery on survival, but the rate of locoregional complications was lower. Therefore, patients should be treated within prospective trials evaluating the role of cytoreductive prostatectomy in low-volume, bone metastatic prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Thomas Steuber, Kasper D. Berg, Martin A. Røder, Klaus Brasso, Peter Iversen, Hartwig Huland, Anne Tiebel, Thorsten Schlomm, Alexander Haese, Georg Salomon, Lars Budäus, Derya Tilki, Hans Heinzer, Markus Graefen, Philipp Mandel,